Abstract
Rationale
Better means to control placebo effects are key to optimizing treatment outcomes. Dopamine-based reward and learning mechanisms have been hypothesized to drive placebo effects. Here, we tested whether dopamine augmentation can modulate learned placebo effects.
Methods
We performed a randomized, double-blind parallel group study with 70 healthy adult participants to test whether a single oral dose of the dopamine precursor levodopa/carbidopa (100/25 mg) administered before the acquisition of conditioned placebo analgesia enhances the placebo response in an established experimental placebo model using heat pain.
Results
Overall, the observed levels of placebo analgesia in our sample were low and not statistically significant. Levodopa, compared to placebo, only led to a marginal increase in placebo analgesia. Female participants tended to show larger placebo responses than male participants. Within the female subgroup, levodopa showed small-to-moderate effects on placebo analgesia; however, this effect was not statistically significant.
Conclusions
In summary, the present study could not provide evidence for a placebo augmenting effect of levodopa-enhanced dopamine levels in healthy subjects. Further studies are needed to elucidate whether placebo enhancement can be achieved through dopamine augmentation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amanzio M, Benedetti F (1999) Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 19:484–494
Au Yeung ST, Colagiuri B, Lovibond PF, Colloca L (2014) Partial reinforcement, extinction, and placebo analgesia. Pain 155:1110–1117. https://doi.org/10.1016/j.pain.2014.02.022
Averbuch M, Katzper M (2001) Gender and the placebo analgesic effect in acute pain. Clin Pharmacol Ther 70:287–291. https://doi.org/10.1067/mcp.2001.118366
Becker S, Ceko M, Louis-Foster M, Elfassy NM, Leyton M, Shir Y, Schweinhardt P (2013a) Dopamine and pain sensitivity: neither sulpiride nor acute phenylalanine and tyrosine depletion have effects on thermal pain sensations in healthy volunteers. PLoS One 8:1–10. https://doi.org/10.1371/journal.pone.0080766
Becker S, Gandhi W, Elfassy NM, Schweinhardt P (2013b) The role of dopamine in the perceptual modulation of nociceptive stimuli by monetary wins or losses. Eur J Neurosci 38:3080–3088. https://doi.org/10.1111/ejn.12303
Bradbrook ID, Gillies HC, Morrison PJ, Rogers HJ (1986) The effects of domperidone on the absorption of levodopa in normal subjects. Eur J Clin Pharmacol 29:721–723. https://doi.org/10.1007/BF00615966
Brainard DH (1997) The psychophysics toolbox. Spat Vis 10:433–436. https://doi.org/10.1007/s13398-014-0173-7.2
Büchel C, Geuter S, Sprenger C, Eippert F (2014) Placebo analgesia: a predictive coding perspective. Neuron 81:1223–1239. https://doi.org/10.1016/j.neuron.2014.02.042
Colloca L, Sigaudo M, Benedetti F (2008) The role of learning in nocebo and placebo effects. Pain 136:211–218. https://doi.org/10.1016/j.pain.2008.02.006
Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F (2010) How the number of learning trials affects placebo and nocebo responses. Pain 151:430–439. https://doi.org/10.1016/j.pain.2010.08.007
de la Fuente-Fernández R (2009) The placebo-reward hypothesis: dopamine and the placebo effect. Park Relat Disord 15:72–74. https://doi.org/10.1016/S1353-8020(09)70785-0
de la Fuente-Fernández R, Ruth TJ, Sossi V et al (2001) Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science 293:1164–1166. https://doi.org/10.1126/science.1060937
de la Fuente-Fernández R, Phillips AG, Zamburlini M et al (2002) Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res 136:359–363. https://doi.org/10.1016/S0166-4328(02)00130-4
Delaveau P, Salgado-Pineda P, Wicker B, Micallef-Roll J??, Blin O (2005) Effect of levodopa on healthy volunteers’ facial emotion perception: an FMRI study. Clin Neuropharmacol 28:255–261
Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Büchel C (2009) Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63:533–543. https://doi.org/10.1016/j.neuron.2009.07.014
Enck P, Bingel U, Schedlowski M, Rief W (2013) The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov 12:191–204. https://doi.org/10.1038/nrd3923
Geuter S, Eippert F, Hindi Attar C, Büchel C (2013) Cortical and subcortical responses to high and low effective placebo treatments. Neuroimage 67:227–236. https://doi.org/10.1016/j.neuroimage.2012.11.029
Glimcher PW (2011) Understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis. Proc Natl Acad Sci U S A 108(Suppl):15647–15654. https://doi.org/10.1073/pnas.1014269108
Guitart-Masip M, Economides M, Huys QJM, Frank MJ, Chowdhury R, Duzel E, Dayan P, Dolan RJ (2014) Differential, but not opponent, effects of l-DOPA and citalopram on action learning with reward and punishment. Psychopharmacology 231:955–966. https://doi.org/10.1007/s00213-013-3313-4
Horing B, Newsome ND, Enck P, Babu SV, Muth ER (2016) A virtual experimenter to increase standardization for the investigation of placebo effects. BMC Med Res Methodol 16:84. https://doi.org/10.1186/s12874-016-0185-4
Kessner S, Sprenger C, Wrobel N, Wiech K, Bingel U (2013) Effect of oxytocin on placebo analgesia: a randomized study. JAMA 310:1733–1735. https://doi.org/10.1001/jama.2013.277446
Khor S-P, Hsu A (2007) The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson’s disease. Curr Clin Pharmacol 2:234–243. https://doi.org/10.2174/157488407781668802
Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Flöel A, Zwitserlood P, Ringelstein EB (2004) Levodopa: faster and better word learning in normal humans. Ann Neurol 56:20–26. https://doi.org/10.1002/ana.20125
Lehr D, Hillert A, Schmitz E, Sosnowsky N (2008) Screening depressiver Störungen mittels Allgemeiner Depressions-Skala (ADS-K) und State-Trait Depressions Scales (STDS-T). Eine vergleichende Evaluation von Cut-Off-Werten. Diagnostica 54:61–70. https://doi.org/10.1026/0012-1924.54.1.
Leknes S, Tracey I (2008) A common neurobiology for pain and pleasure. Nat Rev Neurosci 9:314–320. https://doi.org/10.1038/nrn2333
Leknes S, Lee M, Berna C, Andersson J, Tracey I (2011) Relief as a reward: hedonic and neural responses to safety from pain. PLoS One 6:e17870. https://doi.org/10.1371/journal.pone.0017870
Lidstone SC, Schulzer M, Dinelle K (2011) Effects of expectation on placebo-induced dopamine release in Parkinson’s disease. Focus Park Dis 22:22–24
Linssen AMW, Sambeth A, Vuurman EFPM, Riedel WJ (2014) Cognitive effects of methylphenidate and levodopa in healthy volunteers. Eur Neuropsychopharmacol 24:200–206. https://doi.org/10.1016/j.euroneuro.2013.09.009
Lui F, Colloca L, Duzzi D, Anchisi D, Benedetti F, Porro CA (2010) Neural bases of conditioned placebo analgesia. Pain 151:816–824. https://doi.org/10.1016/j.pain.2010.09.021
Monte-Silva K, Liebetanz D, Grundey J, Paulus W, Nitsche MA (2010) Dosage-dependent non-linear effect of l-dopa on human motor cortex plasticity. J Physiol 588:3415–3424. https://doi.org/10.1113/jphysiol.2010.190181
Montgomery GH, Kirsch I (1997) Classical conditioning and the placebo effect. Pain 72:107–113. https://doi.org/10.1016/S0304-3959(97)00016-X
Nyholm D, Lewander T, Gomes-Trolin C, Bäckström T, Panagiotidis G, Ehrnebo M, Nyström C, Aquilonius SM (2012) Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers. Clin Neuropharmacol 35:111–117. https://doi.org/10.1097/WNF.0b013e31825645d1
Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD (2006) Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442:1042–1045. https://doi.org/10.1038/nature05051
Puig MV, Antzoulatos EG, Miller EK (2014) Prefrontal dopamine in associative learning and memory. Neuroscience 282:217–229. https://doi.org/10.1016/j.neuroscience.2014.09.026
Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401. https://doi.org/10.1177/014662167700100306
Regenthal R, Krueger M, Koeppel C, Preiss R (1999) Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs. J Clin Monit Comput 15:529–544. https://doi.org/10.1023/A:1009935116877
Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2008) Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 65:220–231. https://doi.org/10.1001/archgenpsychiatry.2007.34
Seymour B, O’Doherty JP, Koltzenburg M et al (2005) Opponent appetitive-aversive neural processes underlie predictive learning of pain relief. Nat Neurosci 8:1234–1240. https://doi.org/10.1038/nn1527
Sharot T, Guitart-Masip M, Korn CW, Chowdhury R, Dolan RJ (2012) How dopamine enhances an optimism bias in humans. Curr Biol 22:1477–1481. https://doi.org/10.1016/j.cub.2012.05.053
Strafella AP, Ko JH, Monchi O (2006) Therapeutic application of transcranial magnetic stimulation in Parkinson’s disease: the contribution of expectation. Neuroimage 31:1666–1672. https://doi.org/10.1016/j.neuroimage.2006.02.005
Thirugnanasambandam N, Grundey J, Paulus W, Nitsche MA (2011) Dose-dependent nonlinear effect of l-DOPA on paired associative stimulation-induced neuroplasticity in humans. J Neurosci 31:5294–5299. https://doi.org/10.1523/JNEUROSCI.6258-10.2011
Vaillancourt DE, Schonfeld D, Kwak Y, Bohnen NI, Seidler R (2013) Dopamine overdose hypothesis: evidence and clinical implications. Mov Disord 28:1920–1929. https://doi.org/10.1002/mds.25687
Vase L, Petersen GL, Riley JL, Price DD (2009) Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain 145:36–44. https://doi.org/10.1016/j.pain.2009.04.008
Vo A, Seergobin KN, Morrow SA, MacDonald PA (2016) Levodopa impairs probabilistic reversal learning in healthy young adults. Psychopharmacology 233:2753–2763. https://doi.org/10.1007/s00213-016-4322-x
Weimer K, Colloca L, Enck P (2015) Age and sex as moderators of the placebo response—an evaluation of systematic reviews and meta-analyses across medicine. Gerontology 61:97–108. https://doi.org/10.1159/000365248
Wittmann BC, D’Esposito M (2014) Levodopa administration modulates striatal processing of punishment-associated items in healthy participants. Psychopharmacology 232:135–144. https://doi.org/10.1007/s00213-014-3646-7
Wrobel N, Wiech K, Forkmann K, Ritter C, Bingel U (2014) Haloperidol blocks dorsal striatum activity but not analgesia in a placebo paradigm. Cortex 57:60–73. https://doi.org/10.1016/j.cortex.2014.02.023
Zunhammer M, Ploner M, Engelbrecht C, Bock J, Kessner SS, Bingel U (2017) The effects of treatment failure generalize across different routes of drug administration. Sci Transl Med 9:1–8. https://doi.org/10.1126/scitranslmed.aal2999
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Zunhammer, M., Gerardi, M. & Bingel, U. The effect of dopamine on conditioned placebo analgesia in healthy individuals: a double-blind randomized trial. Psychopharmacology 235, 2587–2595 (2018). https://doi.org/10.1007/s00213-018-4951-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-018-4951-3